Hyperoxidation of ether-linked phospholipids accelerates neutrophil extracellular trap formation

Satoshi Yotsumoto, Yuito Muroi, Tatsuya Chiba, Rio Ohmura, Maki Yoneyama, Megumi Magarisawa, Kosuke Dodo, Naoki Terayama, Mikiko Sodeoka, Ryohei Aoyagi, Makoto Arita, Satoko Arakawa, Shigeomi Shimizu, Masato Tanaka

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Because neutrophil extracellular trap (NET) formation is involved in the pathology of a wide variety of diseases, NET-regulating compounds are expected to be useful for the therapies of these diseases. In this study, we identified sulfasalazine (SSZ) as a potent enhancer of NET formation both in vitro and in vivo. Although SSZ did not increase the amount of ROS generated, it accelerated the generation of ether-linked oxidized phospholipids, such as PE (18;1e/15-HETE) and PC (16;0e/13-HODE). Trolox, but not 2-ME, effectively suppressed lipid oxidation and NET formation that were induced by SSZ. SSZ is known as a potent inducer of ferroptosis in cancer cells by inhibiting xCT, a component of the cystine transporter. However, we found that SSZ accelerated NET formation in an xCT-independent manner. Structure-activity relationship studies revealed that the sulfapyridine moiety of SSZ plays a central role in enhancing NET formation. Furthermore, we found that two additional sulfonamide and sulfone derivatives possess NET-inducing activity by accelerating lipid oxidation. These results indicate that the hyperoxidation of ether-linked phospholipids is a key mechanism for accelerating NET formation.

Original languageEnglish
Article number16026
JournalScientific Reports
Volume7
Issue number1
DOIs
Publication statusPublished - 2017 Dec 1

Fingerprint

Phospholipid Ethers
Sulfasalazine
Sulfapyridine
Lipids
Sulfones
Cystine
Extracellular Traps
Mercaptoethanol
Sulfonamides
Structure-Activity Relationship
Ether
Phospholipids
Pathology

ASJC Scopus subject areas

  • General

Cite this

Yotsumoto, S., Muroi, Y., Chiba, T., Ohmura, R., Yoneyama, M., Magarisawa, M., ... Tanaka, M. (2017). Hyperoxidation of ether-linked phospholipids accelerates neutrophil extracellular trap formation. Scientific Reports, 7(1), [16026]. https://doi.org/10.1038/s41598-017-15668-z

Hyperoxidation of ether-linked phospholipids accelerates neutrophil extracellular trap formation. / Yotsumoto, Satoshi; Muroi, Yuito; Chiba, Tatsuya; Ohmura, Rio; Yoneyama, Maki; Magarisawa, Megumi; Dodo, Kosuke; Terayama, Naoki; Sodeoka, Mikiko; Aoyagi, Ryohei; Arita, Makoto; Arakawa, Satoko; Shimizu, Shigeomi; Tanaka, Masato.

In: Scientific Reports, Vol. 7, No. 1, 16026, 01.12.2017.

Research output: Contribution to journalArticle

Yotsumoto, S, Muroi, Y, Chiba, T, Ohmura, R, Yoneyama, M, Magarisawa, M, Dodo, K, Terayama, N, Sodeoka, M, Aoyagi, R, Arita, M, Arakawa, S, Shimizu, S & Tanaka, M 2017, 'Hyperoxidation of ether-linked phospholipids accelerates neutrophil extracellular trap formation', Scientific Reports, vol. 7, no. 1, 16026. https://doi.org/10.1038/s41598-017-15668-z
Yotsumoto, Satoshi ; Muroi, Yuito ; Chiba, Tatsuya ; Ohmura, Rio ; Yoneyama, Maki ; Magarisawa, Megumi ; Dodo, Kosuke ; Terayama, Naoki ; Sodeoka, Mikiko ; Aoyagi, Ryohei ; Arita, Makoto ; Arakawa, Satoko ; Shimizu, Shigeomi ; Tanaka, Masato. / Hyperoxidation of ether-linked phospholipids accelerates neutrophil extracellular trap formation. In: Scientific Reports. 2017 ; Vol. 7, No. 1.
@article{f16ee66f5107412986041b82b6e69938,
title = "Hyperoxidation of ether-linked phospholipids accelerates neutrophil extracellular trap formation",
abstract = "Because neutrophil extracellular trap (NET) formation is involved in the pathology of a wide variety of diseases, NET-regulating compounds are expected to be useful for the therapies of these diseases. In this study, we identified sulfasalazine (SSZ) as a potent enhancer of NET formation both in vitro and in vivo. Although SSZ did not increase the amount of ROS generated, it accelerated the generation of ether-linked oxidized phospholipids, such as PE (18;1e/15-HETE) and PC (16;0e/13-HODE). Trolox, but not 2-ME, effectively suppressed lipid oxidation and NET formation that were induced by SSZ. SSZ is known as a potent inducer of ferroptosis in cancer cells by inhibiting xCT, a component of the cystine transporter. However, we found that SSZ accelerated NET formation in an xCT-independent manner. Structure-activity relationship studies revealed that the sulfapyridine moiety of SSZ plays a central role in enhancing NET formation. Furthermore, we found that two additional sulfonamide and sulfone derivatives possess NET-inducing activity by accelerating lipid oxidation. These results indicate that the hyperoxidation of ether-linked phospholipids is a key mechanism for accelerating NET formation.",
author = "Satoshi Yotsumoto and Yuito Muroi and Tatsuya Chiba and Rio Ohmura and Maki Yoneyama and Megumi Magarisawa and Kosuke Dodo and Naoki Terayama and Mikiko Sodeoka and Ryohei Aoyagi and Makoto Arita and Satoko Arakawa and Shigeomi Shimizu and Masato Tanaka",
year = "2017",
month = "12",
day = "1",
doi = "10.1038/s41598-017-15668-z",
language = "English",
volume = "7",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Hyperoxidation of ether-linked phospholipids accelerates neutrophil extracellular trap formation

AU - Yotsumoto, Satoshi

AU - Muroi, Yuito

AU - Chiba, Tatsuya

AU - Ohmura, Rio

AU - Yoneyama, Maki

AU - Magarisawa, Megumi

AU - Dodo, Kosuke

AU - Terayama, Naoki

AU - Sodeoka, Mikiko

AU - Aoyagi, Ryohei

AU - Arita, Makoto

AU - Arakawa, Satoko

AU - Shimizu, Shigeomi

AU - Tanaka, Masato

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Because neutrophil extracellular trap (NET) formation is involved in the pathology of a wide variety of diseases, NET-regulating compounds are expected to be useful for the therapies of these diseases. In this study, we identified sulfasalazine (SSZ) as a potent enhancer of NET formation both in vitro and in vivo. Although SSZ did not increase the amount of ROS generated, it accelerated the generation of ether-linked oxidized phospholipids, such as PE (18;1e/15-HETE) and PC (16;0e/13-HODE). Trolox, but not 2-ME, effectively suppressed lipid oxidation and NET formation that were induced by SSZ. SSZ is known as a potent inducer of ferroptosis in cancer cells by inhibiting xCT, a component of the cystine transporter. However, we found that SSZ accelerated NET formation in an xCT-independent manner. Structure-activity relationship studies revealed that the sulfapyridine moiety of SSZ plays a central role in enhancing NET formation. Furthermore, we found that two additional sulfonamide and sulfone derivatives possess NET-inducing activity by accelerating lipid oxidation. These results indicate that the hyperoxidation of ether-linked phospholipids is a key mechanism for accelerating NET formation.

AB - Because neutrophil extracellular trap (NET) formation is involved in the pathology of a wide variety of diseases, NET-regulating compounds are expected to be useful for the therapies of these diseases. In this study, we identified sulfasalazine (SSZ) as a potent enhancer of NET formation both in vitro and in vivo. Although SSZ did not increase the amount of ROS generated, it accelerated the generation of ether-linked oxidized phospholipids, such as PE (18;1e/15-HETE) and PC (16;0e/13-HODE). Trolox, but not 2-ME, effectively suppressed lipid oxidation and NET formation that were induced by SSZ. SSZ is known as a potent inducer of ferroptosis in cancer cells by inhibiting xCT, a component of the cystine transporter. However, we found that SSZ accelerated NET formation in an xCT-independent manner. Structure-activity relationship studies revealed that the sulfapyridine moiety of SSZ plays a central role in enhancing NET formation. Furthermore, we found that two additional sulfonamide and sulfone derivatives possess NET-inducing activity by accelerating lipid oxidation. These results indicate that the hyperoxidation of ether-linked phospholipids is a key mechanism for accelerating NET formation.

UR - http://www.scopus.com/inward/record.url?scp=85034807889&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034807889&partnerID=8YFLogxK

U2 - 10.1038/s41598-017-15668-z

DO - 10.1038/s41598-017-15668-z

M3 - Article

VL - 7

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 16026

ER -